Fox Run Management L.L.C. Buys New Position in Liquidia Corporation $LQDA

Fox Run Management L.L.C. purchased a new position in Liquidia Corporation (NASDAQ:LQDA) during the 3rd quarter, HoldingsChannel reports. The firm purchased 22,325 shares of the company’s stock, valued at approximately $508,000.

A number of other large investors also recently modified their holdings of the business. Whitcomb & Hess Inc. grew its stake in shares of Liquidia by 2.0% in the third quarter. Whitcomb & Hess Inc. now owns 28,385 shares of the company’s stock worth $645,000 after acquiring an additional 558 shares during the last quarter. Steward Partners Investment Advisory LLC raised its stake in Liquidia by 24.0% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 6,200 shares of the company’s stock valued at $77,000 after purchasing an additional 1,200 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new stake in Liquidia in the 3rd quarter valued at $30,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Liquidia by 4.7% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after purchasing an additional 1,700 shares during the last quarter. Finally, Significant Wealth Partners LLC increased its holdings in shares of Liquidia by 16.8% during the 3rd quarter. Significant Wealth Partners LLC now owns 13,131 shares of the company’s stock worth $299,000 after purchasing an additional 1,891 shares during the period. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other Liquidia news, insider Scott Moomaw sold 20,533 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $37.43, for a total transaction of $768,550.19. Following the completion of the transaction, the insider directly owned 154,514 shares in the company, valued at $5,783,459.02. This represents a 11.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CFO Michael Kaseta sold 36,932 shares of the business’s stock in a transaction on Monday, January 12th. The shares were sold at an average price of $37.43, for a total transaction of $1,382,364.76. Following the completion of the sale, the chief financial officer owned 350,919 shares in the company, valued at $13,134,898.17. This represents a 9.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 216,820 shares of company stock valued at $8,102,685. 26.50% of the stock is owned by company insiders.

Liquidia Trading Up 0.7%

Shares of LQDA opened at $31.02 on Friday. The company has a current ratio of 2.20, a quick ratio of 1.96 and a debt-to-equity ratio of 6.19. The stock has a market cap of $2.70 billion, a PE ratio of -21.54, a PEG ratio of 0.87 and a beta of 0.46. Liquidia Corporation has a 1 year low of $11.26 and a 1 year high of $46.67. The stock has a 50 day simple moving average of $37.29 and a 200-day simple moving average of $30.67.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on LQDA. BTIG Research reiterated a “buy” rating and issued a $49.00 target price on shares of Liquidia in a research note on Friday, January 9th. Raymond James Financial reaffirmed a “strong-buy” rating and issued a $47.00 price target on shares of Liquidia in a report on Tuesday, November 4th. Jefferies Financial Group raised their price objective on Liquidia from $45.00 to $55.00 and gave the stock a “buy” rating in a research report on Tuesday, January 13th. Needham & Company LLC restated a “buy” rating and set a $52.00 price objective on shares of Liquidia in a research report on Wednesday. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of Liquidia in a research note on Thursday, January 22nd. Two research analysts have rated the stock with a Strong Buy rating, seven have issued a Buy rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $39.67.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).